Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Asymmetric Lipid Bilayer

Asymmetric Lipid Bilayer

Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...

Lipid Absorption

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

Epistasis Analysis

Epistasis Analysis

Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Child neurodevelopment is related to maternal manganese exposure: A Taiwan national prospective cohort study.

Ecotoxicology and environmental safety·2026

Same author

Caregiver Mental Health and Sociodemographic Factors Associated with the Burden of Care in Taiwan Among Primary Caregivers of Patients with Major Depressive Disorder: A Cross-Sectional Study.

Neuropsychiatric disease and treatment·2026

Same author

Predictive validity of the personal and social performance scale for PANSS outcomes in schizophrenia: a severity-stratified study.

BMC research notes·2026

Same author

Rapid Recurrent Weight Gain Within Two Years of Sleeve Gastrectomy: Clinical Predictors and Metabolic Consequences.

Obesity surgery·2026

Same author

Ethical challenges around mandatory vaccination among nurses: A systematic review of qualitative and quantitative evidence.

International journal of nursing studies·2026

Same author

The clinical utility of the immune status questionnaire as a marker of immune function among persons with schizophrenia.

Science progress·2025

Search research articles

Related Experiment Video

Updated: Jul 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

A module map showing interaction between apolipoprotein E and phospholipase A2 polymorphism in lipid profiles.

For-Wey Lung¹, Wei-Tsung Kao, Bih-Ching Shu

¹Department of Psychiatry, Military Kaohsiung General Hospital, Kaohsiung, Taiwan. forwey@seed.net.tw

|October 24, 2006

Summary

The study found that specific alleles of Apolipoprotein E (Apo E) and Phospholipase A2 (PLA2) influence lipid profiles, particularly LDL-C and HDL-C levels. Co-existence of PLA2 A2 and Apo E epsilon2 alleles significantly alters these lipid levels.

Related Experiment Videos

Last Updated: Jul 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Area of Science:

Genetics and Molecular Biology
Cardiovascular Health
Biochemistry

Background:

Lipid profiles, including High-Density Lipoprotein Cholesterol (HDL-C) and Low-Density Lipoprotein Cholesterol (LDL-C), are critical indicators of cardiovascular health.
Apolipoprotein E (Apo E) and Phospholipase A2 (PLA2) are key proteins involved in lipid metabolism and transport.

Purpose of the Study:

To investigate the potential conceptual relationship between genetic polymorphisms in Apo E and PLA2 and their impact on lipid profiles.
To assess how specific alleles of Apo E and PLA2 influence levels of HDL-C and LDL-C in an elderly population.

Main Methods:

A cohort of 500 elderly individuals (65-74 years) was recruited from southern Taiwan.
DNA was extracted from 256 participants for genotyping of Apo E and PLA2 polymorphisms.
Multiple linear regression analysis was employed to determine the association between genetic variants and lipid profiles.

Main Results:

The PLA2 A2 allele significantly influenced LDL-C levels (p = 0.0097).
The Apo E epsilon2 allele significantly influenced HDL-C levels (p = 0.0004).
A significant interaction between PLA2 A2 and Apo E epsilon2 alleles was observed for both HDL-C (p = 0.0388) and LDL-C (p = 0.0002), with co-existence leading to decreased HDL-C and increased LDL-C.

Conclusions:

Genetic variations in Apo E and PLA2 play a significant role in regulating HDL-C and LDL-C levels.
The interplay between Apo E and PLA2 polymorphisms affects lipid profiles, highlighting a complex homeostatic mechanism.
This understanding may offer novel therapeutic strategies for complex disorders influenced by lipid metabolism.